Page last updated: 2024-08-24

capecitabine and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide

capecitabine has been researched along with n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beijnen, JH; Copalu, W; Etienne-Grimaldi, MC; Huitema, AD; Milano, G; Schellens, JH; Siegel-Lakhai, WS; Zandvliet, AS1
Beijnen, JH; DiƩras, V; Girre, V; Huitema, AD; King, A; Milano, G; Richmond, E; Schellens, JH; Siegel-Lakhai, WS; Tibben, MM; Wanders, J; Zandvliet, AS1

Trials

1 trial(s) available for capecitabine and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide

ArticleYear
PK/PD model of indisulam and capecitabine: interaction causes excessive myelosuppression.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Drug Administration Schedule; Drug Interactions; Female; Fluorouracil; Humans; Male; Middle Aged; Models, Biological; Neutropenia; Sulfonamides

2008

Other Studies

1 other study(ies) available for capecitabine and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide

ArticleYear
A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours.
    British journal of cancer, 2008, Apr-22, Volume: 98, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Capecitabine; Cytochrome P-450 CYP2C9; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Sulfonamides

2008